<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Journal of Pharmaceutical Research and Integrated Medical Sciences</journal-title>
        <abbrev-journal-title abbrev-type="publisher">jprims</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">3049-1681</issn>
      <publisher>
        <publisher-name>Dr. Arpan Kumar Tripathi</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">jprims-00000008</article-id>
      <title-group>
        <article-title>An Overview of Nanoparticle-Based Approaches for Targeted Therapy in Cardiovascular Diseases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sharma</surname>
            <given-names>Govind </given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Verma</surname>
            <given-names>Vinay Sagar </given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">KIPS, Shrishankaracharya Professional University, (C.G). India</aff>
      <pub-date pub-type="epub" iso-8601-date="2026">
        <year>2026</year>
      </pub-date>
      <volume>1</volume>
      <issue>1</issue>
      <abstract>
        <p>
Nanoparticle-based medicate conveyance frameworks, moreover known as nano-DDSs, show a promising approach to focused on treatment within the treatment of cardiovascular illnesses (CVDs), which incorporate heart disappointment, arrhythmia, atherosclerosis, and myocardial dead tissue. A diagram of the use of nanoparticles within the conclusion and treatment of cardiovascular infection (CVD) is displayed in this work. The nanoparticles that are examined incorporate natural and inorganic nanoparticles, as well as multifunctional nanoparticles. Nano-DDSs have the capacity to move forward restorative results whereas simultaneously minimising side responses and focusing on particular zones. Usually fulfilled by precisely conveying solutions to atherosclerotic plaques and encompassing tissues. In expansion, these innovations make strides demonstrative capabilities of imaging modalities counting attractive reverberation imaging (MRI) and computed tomography (CT). The application of nanotechnology permits for the determination of issues such as non-specific cytotoxicity, destitute dissolvability, and restricted bioavailability. Both the plausibility of custom fitted sedate conveyance and the advance that has been made in cardiovascular nanomedicine have the potential to upgrade quiet results significantly.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
